A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
Mirae Asset Nifty 500 Healthcare ETF
1 Year Absolute Returns
-
NAV (₹) on 27 Mar 2026
18.13
1 Day NAV Change
-0.72%
Risk Level
Very High Risk
Rating
-
Mirae Asset Nifty 500 Healthcare ETF is a Equity mutual fund categorized under ETF, offered by Mirae Asset Global Investments (India) Pvt. Ltd.. Launched on 27 Jan 2026, investors can start with a ... Read more
NAV History
Fund Details
Min. SIP Amount
N/A
Inception Date
27 Jan 2026
Min. Lumpsum Amount
₹ 5,000
Fund Age
0 Yrs
AUM
₹ 7.29 Cr.
Benchmark
Nifty500 Healthcare Total Return
Expense Ratio
0.11%
Scheme Type
Open Ended
Exit Load
Nil%
Asset Allocation
AUM
₹ 7.29 Cr
Equity
99.87%
Money Market & Cash
0.07%
Other Assets & Liabilities
0.06%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 74.28% |
| Hospitals & Medical Services | 24.76% |
| Services - Others | 0.43% |
| Medical Equipment & Accessories | 0.40% |
| Treps/Reverse Repo | 0.07% |
| Net Receivables/(Payables) | 0.06% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.02% | ₹ 0.73 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 6.80% | ₹ 0.50 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 6.78% | ₹ 0.49 | Hospitals & Medical Services |
| Apollo Hospitals Enterprise Ltd. | 6.72% | ₹ 0.49 | Hospitals & Medical Services |
| Dr. Reddy's Laboratories Ltd. | 6.54% | ₹ 0.48 | Pharmaceuticals |
| Cipla Ltd. | 6.33% | ₹ 0.46 | Pharmaceuticals |
| Lupin Ltd. | 4.66% | ₹ 0.34 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 4.10% | ₹ 0.30 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 3.78% | ₹ 0.28 | Pharmaceuticals |
| Laurus Labs Ltd. | 3.49% | ₹ 0.25 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 2.85% | ₹ 0.21 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 2.75% | ₹ 0.20 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 2.69% | ₹ 0.20 | Pharmaceuticals |
| Biocon Ltd. | 2.32% | ₹ 0.17 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.12% | ₹ 0.15 | Pharmaceuticals |
| Zydus Lifesciences Ltd. | 1.93% | ₹ 0.14 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 1.77% | ₹ 0.13 | Pharmaceuticals |
| Krishna Institute of Medical Sciences Ltd. | 1.54% | ₹ 0.11 | Hospitals & Medical Services |
| JB Chemicals & Pharmaceuticals Ltd. | 1.40% | ₹ 0.10 | Pharmaceuticals |
| Aster DM Healthcare Ltd. | 1.27% | ₹ 0.09 | Hospitals & Medical Services |
| Gland Pharma Ltd. | 1.21% | ₹ 0.09 | Pharmaceuticals |
| Sai Life Sciences Ltd. | 1.14% | ₹ 0.08 | Pharmaceuticals |
| Abbott India Ltd. | 1.13% | ₹ 0.08 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 1.05% | ₹ 0.08 | Pharmaceuticals |
| Narayana Hrudayalaya Ltd. | 1.04% | ₹ 0.08 | Hospitals & Medical Services |
| Wockhardt Ltd. | 0.94% | ₹ 0.07 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 0.92% | ₹ 0.07 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 0.90% | ₹ 0.07 | Hospitals & Medical Services |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.89% | ₹ 0.06 | Pharmaceuticals |
| Piramal Pharma Ltd. | 0.81% | ₹ 0.06 | Pharmaceuticals |
| Global Health Ltd. | 0.80% | ₹ 0.06 | Hospitals & Medical Services |
| Natco Pharma Ltd. | 0.74% | ₹ 0.05 | Pharmaceuticals |
| Granules India Ltd. | 0.70% | ₹ 0.05 | Pharmaceuticals |
| Syngene International Ltd. | 0.67% | ₹ 0.05 | Pharmaceuticals |
| Pfizer Ltd. | 0.64% | ₹ 0.05 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 0.62% | ₹ 0.05 | Pharmaceuticals |
| Eris Lifesciences Ltd. | 0.61% | ₹ 0.04 | Pharmaceuticals |
| Jubilant Pharmova Ltd. | 0.58% | ₹ 0.04 | Pharmaceuticals |
| Rainbow Children's Medicare Ltd. | 0.50% | ₹ 0.04 | Hospitals & Medical Services |
| AstraZeneca Pharma India Ltd. | 0.45% | ₹ 0.03 | Pharmaceuticals |
| Indegene Ltd. | 0.43% | ₹ 0.03 | Services - Others |
| Cohance Lifesciences Ltd. | 0.42% | ₹ 0.03 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 0.41% | ₹ 0.03 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Ltd. | 0.41% | ₹ 0.03 | Hospitals & Medical Services |
| Polymedicure Ltd. | 0.40% | ₹ 0.03 | Medical Equipment & Accessories |
| Emcure Pharmaceuticals Ltd. | 0.36% | ₹ 0.03 | Pharmaceuticals |
| Concord Biotech Ltd. | 0.34% | ₹ 0.02 | Pharmaceuticals |
| Alembic Pharmaceuticals Ltd. | 0.33% | ₹ 0.02 | Pharmaceuticals |
| Dr. Agarwals Health Care Ltd. | 0.29% | ₹ 0.02 | Hospitals & Medical Services |
| Caplin Point Laboratories Ltd. | 0.28% | ₹ 0.02 | Pharmaceuticals |
| TREPS | 0.07% | ₹ 0.01 | Others |
| Net Receivables / (Payables) | 0.06% | ₹ 0 | Others |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | - | - | - | - |
| Category returns | -5.48% | 2.41% | 6.49% | 24.20% |
Fund Objective
The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty 500 Healthcare Total Return Index, subject to tracking error. ... Read more
AMC Details
Name
Mirae Asset Global Investments (India) Pvt. Ltd.
Date of Incorporation
30 Nov 2007
CEO
Mr. Swarup Anand Mohanty
CIO
Mr. Neelesh Surana, Mr. Mahendra Kumar Jajoo
Type
Foreign
Address
Unit 606, 6th Floor, Windsor,
Off CST Road,
Kalina,
Santacruz (E), Mumbai, Maharashtra, India - 400098
Website
http://www.miraeassetmf.co.in
Email
Top Funds from Others - Index Funds/ETFs
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ICICI Prudential Nifty Bank Index Fund
Index
Regular
|
₹14.62 | 1.35% | 32.34% | 0.00% | ₹704 | 0.76% |
Very High
|
|
ICICI Prudential Nifty Bank Index Fund
Index
Regular
|
₹14.62 | 1.35% | 32.34% | 0.00% | ₹704 | 0.76% |
Very High
|
|
ICICI Prudential Nifty Bank Index Fund
Index
Regular
|
₹14.62 | 1.35% | 32.34% | 0.00% | ₹704 | 0.76% |
Very High
|
|
ICICI Prudential BSE Sensex ETF
ETF
Regular
|
₹840.29 | -4.14% | 32.27% | 59.03% | ₹26,710 | 0.02% |
Very High
|
|
Axis Nifty 100 Index Fund
Index
Regular
|
₹18.84 | -7.93% | 32.26% | 52.53% | ₹1,984 | 0.92% |
Very High
|
|
Axis Nifty 100 Index Fund
Index
Regular
|
₹18.84 | -7.93% | 32.26% | 52.53% | ₹1,984 | 0.92% |
Very High
|
|
Nippon India ETF BSE Sensex
ETF
Regular
|
₹840.28 | -4.15% | 32.24% | 58.89% | ₹23,641 | 0.07% |
Very High
|
|
HDFC BSE Sensex ETF
ETF
Regular
|
₹82.91 | -4.16% | 32.14% | 58.85% | ₹537 | 0.05% |
Very High
|
|
Aditya Birla Sun Life BSE Sensex ETF
ETF
Regular
|
₹73.69 | -4.11% | 32.14% | 58.75% | ₹284 | 0.04% |
Very High
|
|
UTI BSE Sensex ETF
ETF
Regular
|
₹809.72 | -4.14% | 32.13% | 58.82% | ₹53,583 | 0.05% |
Very High
|
Top Funds from Mirae Asset Global Investments (India) Pvt. Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Mirae Asset Midcap Fund
Diversified
Regular
|
₹22.06 | -1.16% | 32.42% | 39.78% | ₹18,070 | 1.65% |
Very High
|
|
Mirae Asset Midcap Fund
Diversified
Regular
|
₹22.06 | -1.16% | 32.42% | 39.78% | ₹18,070 | 1.65% |
Very High
|
|
Mirae Asset Great Consumer Fund - Direct Plan
Diversified
Direct
|
₹58.59 | -1.62% | 28.49% | 43.81% | ₹4,473 | 0.44% |
Very High
|
|
Mirae Asset Great Consumer Fund - Direct Plan
Diversified
Direct
|
₹58.59 | -1.62% | 28.49% | 43.81% | ₹4,473 | 0.44% |
Very High
|
|
Mirae Asset Balanced Advantage Fund
Hybrid
Regular
|
₹12.70 | -5.00% | 28.20% | 0.00% | ₹2,053 | 2.04% |
Very High
|
|
Mirae Asset Balanced Advantage Fund
Hybrid
Regular
|
₹12.70 | -5.00% | 28.20% | 0.00% | ₹2,053 | 2.04% |
Very High
|
|
Mirae Asset Focused Fund - Direct Plan
MidsmallCap
Direct
|
₹23.40 | -7.95% | 26.55% | 46.13% | ₹7,033 | 0.61% |
Very High
|
|
Mirae Asset Arbitrage Fund - Direct Plan
Hybrid
Direct
|
₹14.18 | 6.92% | 25.09% | 37.72% | ₹3,834 | 0.15% |
Low
|
|
Mirae Asset Nifty SDL Jun 2027 Index Fund - Direct Plan
Index
Direct
|
₹12.91 | 7.24% | 25.09% | 0.00% | ₹510 | 0.18% |
Low to Moderate
|
|
Mirae Asset Nifty SDL Jun 2027 Index Fund - Direct Plan
Index
Direct
|
₹12.91 | 7.24% | 25.09% | 0.00% | ₹510 | 0.18% |
Low to Moderate
|
FAQs
What is the current NAV of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
The current Net Asset Value (NAV) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth is ₹18.13 as of 27 Mar 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
The Assets Under Management (AUM) of Mirae Asset Nifty 500 Healthcare ETF Regular Growth is ₹7.29 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
Mirae Asset Nifty 500 Healthcare ETF Regular Growth has delivered returns of 0.00% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
Mirae Asset Nifty 500 Healthcare ETF Regular Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Mirae Asset Nifty 500 Healthcare ETF Regular Growth?
The minimum lumpsum investment required for Mirae Asset Nifty 500 Healthcare ETF Regular Growth is ₹5,000. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
The Best Way To Build A Mutual Fund Portfolio In Your 20s, 30s And 40s -
How To Gift Mutual Funds To Children: Rules, Tax Implications And Process Explained -
How to Position Portfolio Amid Global Tensions, Rising Gold,Silver ETF Inflows? Navi CEO Aditya Mulki Explains -
NPS vs Mutual Funds For Retirement: Which Investment Option Offers Better Growth, Tax Benefits And Stability? -
Big Shake-Up in Mutual Funds! SEBI Scraps Solution Funds, Introduces Life-Cycle Category | 5 Changes Explained -
Selling Mutual Funds? Here’s How You Can Save Capital Gains Tax Under Section 54F -
What Are Multi-Cap Mutual Funds? Single Fund Exposure to Large, Mid and Small-Cap Stocks; Know Details -
Can UAE-Based NRIs Invest In Indian Mutual Funds? Rules, Taxes And DTAA Explained -
What Is A Balanced Advantage Fund (BAF) And How Does It Work? -
Are Retirement Mutual Funds The Right Choice For Long-Term Investment Planning?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+